American Oncology Network | Cancer and Blood Specialists of Arizona

Research site

Location

1281 E Cottonwood Lane, Casa Grande, Arizona, United States of America

Site insights

Top conditions

Top treatments

Durvalumab

Etoposide Versus Durvalumab

[177Lu]Lu-PSMA-617

Carboplatin

Etoposide

177Lu-PSMA-617

Lutetium (177Lu) Vipivotide Tetraxetan

Tarlatamab

Parent organization

This site is a part of American Oncology Network

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Robin Wilson

Verified by this site

Active trials

2 of 3 total trials

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) (DeLLphi-312)

The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination...

Enrolling

Small-cell Lung Cancer

Extensive Stage Small-cell Lung Cancer

Drug: Tarlatamab

Drug: Carboplatin

An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC (PSMAndARPI)

The purpose of this study is to assess safety of combination of AAA617 (administered for 6 cycles at a dose of 7.4 GBq (200 mCi) +/- 10%) and ARPI an...

Active, not recruiting

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Drug: AAA617

Drug: ARPI: Abiraterone

Trial sponsors

F

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms